Further, in patients with early-stage disease, namely KL I and II knee OA with and without MetS, significant increases in serum COMP, a biomarker of cartilage degeneration, in MetS-OA was noted when compared to non-MetS OA, and positively correlated with hypertriglyceridemia [33]. Here, COMP is linked to metabolic syndrome.